聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 42 分钟 52 秒 前

MEI Pharma Adds Former VC David Urso as Senior Vice President of Corporate Development and General Counsel

周二, 04/08/2014 - 15:36
SAN DIEGO, April 8, 2014 -- (Healthcare Sales & Marketing Network) -- MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today the appointment of David Urso as Senior Vice President of...
Biopharmaceuticals, Oncology, Personnel
MEI Pharma, Pracinostat, histone deacetylase

CardiAQ(TM) Valve Technologies Inc. (CardiAQ) appoints Paul Cornelison as Vice President of Regulatory Affairs, Quality Assurance and Clinical Affairs

周二, 04/08/2014 - 15:34
“Paul brings a wealth of mitral space experience, and I am personally delighted that he has chosen to join CardiAQ to help solidify our position as the undisputed leader in percutaneous mitral valve replacement as an alternative to open heart surgery.” - R...
Devices, Interventional Cardiology, Personnel
CardiAQ Valve Technologies, Transcatheter, Mitral Valve, heart valve

Epic Sciences Appoints Pascal Bamford, Ph.D. as Vice President of Product Development

周二, 04/08/2014 - 15:31
Creative innovator to advance Epic's CTC technology for rapid analysis of cancer for patient matching to clinical trials, therapeutic selection and resistance monitoring SAN DIEGO, April 8, 2014 -- (Healthcare Sales & Marketing Network) -- Epic Science...
Diagnostics, Personalized Medicine, Oncology, Personnel
Epic Sciences, circulating tumor cells

Mitralign Completes Enrollment in EU Study for its Novel Catheter-based Valve Repair Device

周二, 04/08/2014 - 15:28
Company to seek CE Mark for new first-line percutaneous treatment of functional mitral regurgitation TEWKSBURY, Mass.--(Healthcare Sales & Marketing Network)--Mitralign Inc., a cardiac device company, announced today it has completed enrollment in a stu...
Devices, Interventional Cardiology
Mitralign, transcatheter, mitral valve, annuloplasty, mitral regurgitation

Fresenius Medical Care Renal Therapies Group Announces Chief Medical Officer to Retire

周二, 04/08/2014 - 15:24
Incoming CMO of company’s products business to assume position as of July 1, 2014 WALTHAM, Mass.--(Healthcare Sales & Marketing Network)--Fresenius Medical Care Renal Therapies Group (RTG) , the continent’s leading provider of kidney care products, ann...
Devices, Personnel
Fresenius Medical Care, Renal Therapies Group, dialysis

Atara Biotherapeutics Strengthens Board and Senior Management Team

周二, 04/08/2014 - 13:40
Matthew K. Fust joins Board of Directors Mitchall G. Clark named Chief Regulatory and Quality Assurance Officer BRISBANE & THOUSAND OAKS, Calif.--(Healthcare Sales & Marketing Network)--Atara Biotherapeutics, Inc., a drug development company with a ...
Biopharmaceuticals, Personnel
Atara Biotherapeutics, TGF-beta, myostatin, activin

JenaValve Expands Series C Venture Financing Round

周二, 04/08/2014 - 13:31
Valiance and RMM Join Second Closing Bringing Total Round to $72.5 Million; New Board Member Appointed WILMINGTON, Del. & MUNICH--(Healthcare Sales & Marketing Network)--JenaValve Technology, Inc., a privately-held, venture-backed developer, manufacture...
Devices, Interventional Cardiology, Venture Capital
JenaValve Technology, TAVI, transcatheter, JenaClip, aortic valve

Takeda Responds to Verdict in Diabetes Drug Case

周二, 04/08/2014 - 13:22
DEERFIELD, Ill., April 8, 2014 -- (Healthcare Sales & Marketing Network) -- Takeda Pharmaceuticals U.S.A., Inc. announced that in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al, No. 6:12-cv-00064 the jury found in ...
Biopharmaceuticals, Endocrinology, Litigation
Takeda Pharmaceuticals, Eli Lilly, ACTOS , pioglitazone, diabetes

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong